ROST
70
2
PFE
38
2
LNC
70
-2
PEG
50
4
AEE
58
3
HPE
68
-5
TRIP
52
2
VMC
59
2
FITB
72
2
DRI
64
4
HSY
50
5
BLK
61
-2
TGT
52
2
DVN
40
-2
STI
15
-6
GT
39
2
KMB
33
2
MMC
60
3
FTI
61
-2
SIG
52
2
ROST
70
2
PFE
38
2
LNC
70
-2
PEG
50
4
AEE
58
3
HPE
68
-5
TRIP
52
2
VMC
59
2
FITB
72
2
DRI
64
4
HSY
50
5
BLK
61
-2
TGT
52
2
DVN
40
-2
STI
15
-6
GT
39
2
KMB
33
2
MMC
60
3
FTI
61
-2
SIG
52
2
Financhill
Back

Invesco Bloomberg Analyst Rating Improvers ETF Vs. Travere Therapeutics, Inc. Industry Stock Comparison

Buy
58

UPGD
Invesco Bloomberg Analyst Rating Improvers ETF

Last Price:
$75.17
Seasonality Move:
5.42%
Buy
80

TVTX
Travere Therapeutics, Inc.

Last Price:
$40.3200
Seasonality Move:
33.23%
Buy
58
Invesco Bloomberg Analyst Rating Improvers ETF (UPGD) is a Buy

Is Invesco Bloomberg Analyst Rating Improvers ETF a Buy, Sell or Hold?

  • The current Invesco Bloomberg Analyst Rating Improvers ETF [UPGD] share price is $75.15. The Score for UPGD is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
  • UPGD is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
80
Travere Therapeutics, Inc. (TVTX) is a Buy

Is Travere Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Travere Therapeutics, Inc. [TVTX] share price is $40.2800. The Score for TVTX is 80, which is 60% above its historic median score of 50, and infers lower risk than normal.
  • TVTX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

UPGD Stock Price Chart

What is Invesco Bloomberg Analyst Rating Improvers ETF's stock price today?

  • The Invesco Bloomberg Analyst Rating Improvers ETF share price today is $75.15
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and UPGD is experiencing buying pressure, which is a positive indicator for future bullish movement.

TVTX Stock Price Chart

What is Travere Therapeutics, Inc.'s stock price today?

  • The Travere Therapeutics, Inc. share price today is $40.2800
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TVTX is experiencing slight buying pressure.

UPGD Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 18.63 Buy
Relative Strength Index (14 RSI): 52.1 Buy
Chaikin Money Flow: 2951 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (73.11 - 76.09) Buy
Bollinger Bands (100): (73.12 - 75.4) Buy

TVTX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 9.67 Buy
Relative Strength Index (14 RSI): 69.35 Buy
Chaikin Money Flow: 1508490 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (34.0318 - 36.4718) Buy
Bollinger Bands (100): (20.7309 - 34.2909) Buy

UPGD Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 75.8 Sell
20-day SMA: 75.27 Sell
50-day SMA: 74.24 Buy
200-day SMA: 71.99 Buy
8-day EMA: 54.01 Buy
20-day EMA: 29.75 Buy
50-day EMA: 13.7 Buy
200-day EMA: 3.69 Buy

TVTX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 35.7 Buy
20-day SMA: 35.23 Buy
50-day SMA: 33.43 Buy
200-day SMA: 22.2 Buy
8-day EMA: 28.52 Buy
20-day EMA: 16.32 Buy
50-day EMA: 7.67 Buy
200-day EMA: 2.09 Buy

Invesco Bloomberg Analyst Rating Improvers ETF Earnings Growth & UPGD Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Travere Therapeutics, Inc. Earnings Growth & TVTX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.54 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.58 per share, and an increase next year of $1.08 per share.

Invesco Bloomberg Analyst Rating Improvers ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Travere Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):